ACORDA THERAPEUTICS INC (ACOR) 23.90 $0.25 (1.06%) 05:01AM (15 mins delay)

ACOR

$23.90 $0.25 (1.06%)

You need to upgrade your Flash Player

Today

10y

Last:	$23.90	High:	-
Prev Close:	$23.65	Low:	-
Open:	-	Mkt Cap:	$902M
Change:	$0.25 ( 1.06% )	52Wk High:	$29.27
Vol:	0	52Wk Low:	$14.42
Avg Volume:	528,878	Shares:	38.12B
EPS:	-2.17	PE Ratio:	-

Start trading ACOR with real money!

Company Description

A biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury & other disorders of the central nervous system.

	OptionsZone via Twitter	Nov 04 11:14 AM
	$ACOR Jan option IV of 50 is below its 6-month avg of 90, suggesting decreasing price movement Comment Comment Also post on Twitter. (What is Twitter?) Twitter Username: Password:

	Daryl Story via Twitter	Nov 02 10:50 PM
	Enzyme helps rats with #spinalcord injury. http://bit.ly/40ygLe $ACOR #neurology #biotechnology #investing www.neurobiotech.net Comment Comment Also post on Twitter. (What is Twitter?) Twitter Username: Password:

	Daryl Story via Twitter	Nov 01 10:08 PM
	#Acorda takeover target? So says this money manager -$50/share! $ACOR #biotechnology #MS #multiplesclerosis #investing http://bit.ly/2XUS5O Comment Comment Also post on Twitter. (What is Twitter?) Twitter Username: Password:

	Paul & Shark	Oct 09 10:43 AM
	SELL www.mkapital.com - ACOR Comment Comment Also post on Twitter. (What is Twitter?)

ACORDA THERAPEUTICS INC (ACOR) Stock News & Analysis

	Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference	11/16/2009
	Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics	11/10/2009
	Zacks Bull and Bear of the Day Highlights: Acorda Therapeutics, Canon, Big Lots, Wal-Mart and Nordstrom	11/06/2009
	Acorda Therapeutics Reports Third Quarter 2009 Financial Results	11/03/2009
	Acorda Therapeutics to Host Conference Call to Report Third Quarter 2009 Financial Results on November 3, 2009	10/27/2009
	Acorda Therapeutics Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010	10/22/2009
	Zacks Analyst Blog Highlights: Biogen Idec Inc., Facet Biotech Corporation, Trubion Pharmaceuticals, Bristol-Myers Squibb and Acorda Therapeutics	10/20/2009
	On Small Cap Drug Makers and Volatility	10/18/2009
	StockSource.us Reports on MNDP -- Pioneering Surveillance Technologies	10/16/2009
	Equities Update: Late Rally	10/15/2009
	Today's Pharmaceutical Big Gainers: Acorda Therapeutics, Solta Medical	10/15/2009
	The Stock Alarm Issues Morning Alert On Companies That May Have Unusual Moves: Acorda Therapeutics Inc., Cit Group Inc., Lazard Ltd. and WD-40 Co.	10/15/2009
	The Stock Alarm Issues Morning Alert On Companies That May Have Unusual Moves: Acorda Therapeutics Inc., Cit Group Inc., Lazard Ltd. and WD-40 Co.	10/15/2009
	Positive FDA Panel Outcome for Acorda Therapeutics	10/15/2009
	Acorda Therapeutics Announces Positive Vote by FDA Advisory Committee for Fampridine-SR	10/14/2009